{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:16:17Z","timestamp":1776806177437,"version":"3.51.2"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neuroinform."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Neuroblastoma is the most common extracranial solid tumor of childhood, arising from the sympathetic nervous system. High-risk neuroblastoma (HRNB) remains a major therapeutic challenge with low survival rates despite the intensification of therapy. This study aimed to develop a malignant-cell marker gene signature (MMGS) that might serve as a prognostic indicator in HRNB patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multi-omics datasets, including mRNA expression (single-cell and bulk), DNA methylation, and clinical information of HRNB patients, were used to identify prognostic malignant cell marker genes. MMGS was established by univariate Cox analysis, LASSO, and stepwise multivariable Cox regression analysis. Kaplan\u2013Meier (KM) curve and time-dependent receiver operating characteristic curve (tROC) were used to evaluate the prognostic value and performance of MMGS, respectively. MMGS further verified its reliability and accuracy in the independent validation set. Finally, the characteristics of functional enrichment, tumor immune features, and inflammatory activity between different MMGS risk groups were also investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We constructed a prognostic model consisting of six malignant cell maker genes (MAPT, C1QTNF4, MEG3, NPW, RAMP1, and CDT1), which stratified patients into ultra-high-risk (UHR) and common-high-risk (CHR) group. Patients in the UHR group had significantly worse overall survival (OS) than those in the CHR group. MMGS was verified as an independent predictor for the OS of HRNB patients. The area under the curve (AUC) values of MMGS at 1-, 3-, and 5-year were 0.78, 0.693, and 0.618, respectively. Notably, functional enrichment, tumor immune features, and inflammatory activity analyses preliminarily indicated that the poor prognosis in the UHR group might result from the dysregulation of the metabolic process and immunosuppressive microenvironment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study established a novel six-malignant cell maker gene prognostic model that can be used to predict the prognosis of HRNB patients, which may provide new insight for the treatment and personalized monitoring of HRNB patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fninf.2022.1034793","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T12:44:41Z","timestamp":1668084281000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Zijun","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4143\/crt.2016.511","article-title":"Topotecan-vincristine-doxorubicin in stage 4 high-risk neuroblastoma patients failing to achieve a complete metastatic response to rapid cojec: A siopen study.","volume":"50","author":"Amoroso","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ejhg.2014.72","article-title":"Novel deletions affecting the Meg3-Dmr provide further evidence for a hierarchical regulation of imprinting in 14q32.","volume":"23","author":"Beygo","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1158\/1078-0432.CCR-07-4461","article-title":"Whole chromosome alterations predict survival in high-risk neuroblastoma without Mycn amplification.","volume":"14","author":"Bilke","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold tumors: A therapeutic challenge for immunotherapy.","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front. Immunol."},{"key":"B5","first-page":"1511","article-title":"Expression of the licensing factors, Cdt1 and geminin, in human colon cancer.","volume":"27","author":"Bravou","year":"2005","journal-title":"Int. J. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species.","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s11427-016-0054-1","article-title":"Identifying and annotating human bifunctional rnas reveals their versatile functions.","volume":"59","author":"Chen","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The international neuroblastoma risk group (Inrg) classification system: An inrg task force report.","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cne.20669","article-title":"Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons. Dorsal root ganglia, and the spinal cord of the rat.","volume":"490","author":"Cottrell","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-11-0610","article-title":"Mirna expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.","volume":"17","author":"De Preter","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-10-r95","article-title":"Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.","volume":"13","author":"Decock","year":"2012","journal-title":"Genome Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy.","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/jnci\/djy022","article-title":"Genomic amplifications and distal 6q loss: Novel markers for poor survival in high-risk neuroblastoma patients.","volume":"110","author":"Depuydt","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"B14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ccell.2020.08.014","article-title":"Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma.","volume":"38","author":"Dong","year":"2020","journal-title":"Cancer Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression.","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neo.2020.11.001","article-title":"Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.","volume":"23","author":"Fernandez-Blanco","year":"2021","journal-title":"Neoplasia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1158\/1078-0432.CCR-11-2483","article-title":"A three-gene expression signature model for risk stratification of patients with neuroblastoma.","volume":"18","author":"Garcia","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01582-2","article-title":"Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.","volume":"39","author":"George","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","article-title":"Gsva: Gene set variation analysis for microarray and Rna-Seq data.","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/cac2.12016","article-title":"Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma.","volume":"40","author":"He","year":"2020","journal-title":"Cancer Commun. Lond"},{"key":"B21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and roc curves.","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response.","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1158\/0008-5472.CAN-15-2507","article-title":"Integrative genome-scale analysis identifies epigenetic mechanisms of transcriptional deregulation in unfavorable neuroblastomas.","volume":"76","author":"Henrich","year":"2016","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised neuroblastoma risk classification system: A report from the children\u2019s oncology group.","volume":"39","author":"Irwin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0002-9440(10)63393-7","article-title":"Overexpression of the replication licensing regulators Hcdt1 and Hcdc6 characterizes a subset of non-small-cell lung carcinomas: Synergistic effect with mutant P53 on tumor growth and chromosomal instability\u2013evidence of E2f-1 transcriptional control over Hcdt1.","volume":"165","author":"Karakaidos","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(17)30070-0","article-title":"Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (Hr-Nbl1\/Siopen): An international, randomised, multi-arm, open-label, phase 3 trial.","volume":"18","author":"Ladenstein","year":"2017","journal-title":"Lancet Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2011.05.005","article-title":"Identification of C1qtnf-related protein 4 as a potential cytokine that stimulates the stat3 and Nf-Kappab pathways and promotes cell survival in human cancer cells.","volume":"308","author":"Li","year":"2011","journal-title":"Cancer Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.12.039","article-title":"C1q\/Tnf-related protein 4 induces signal transducer and activator of transcription 3 pathway and modulates food intake.","volume":"429","author":"Li","year":"2020","journal-title":"Neuroscience"},{"key":"B29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (Msigdb) hallmark gene set collection.","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"B30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/cmi.2016.16","article-title":"Expression of the novel adipokine C1qtnf-related protein 4 (Ctrp4) suppresses colitis and colitis-associated colorectal cancer in mice.","volume":"13","author":"Luo","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma.","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and comprehensive analysis of somatic variants in cancer.","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1210\/me.2014-1304","article-title":"Epigenetic regulation of the lncrna Meg3 and its target C-Met in pancreatic neuroendocrine tumors.","volume":"29","author":"Modali","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of alk as a major familial neuroblastoma predisposition gene.","volume":"455","author":"Mosse","year":"2008","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.2000.2390","article-title":"Rat receptor-activity-modifying proteins (Ramps) for adrenomedullin\/cgrp receptor: Cloning and upregulation in obstructive nephropathy.","volume":"270","author":"Nagae","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28328","article-title":"Meg3 and Meg8 aberrant methylation in an infant with neuroblastoma.","volume":"67","author":"Novak","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.811297","article-title":"Garcia de protein tyrosine phosphatases in neuroblastoma: Emerging roles as biomarkers and therapeutic targets.","volume":"9","author":"Nunes-Xavier","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era.","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10110862","article-title":"Emerging evidences for an implication of the neurodegeneration-associated protein tau in cancer.","volume":"10","author":"Papin","year":"2020","journal-title":"Brain Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell Rna-Seq highlights intratumoral heterogeneity in primary glioblastoma.","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies.","volume":"11","author":"Petitprez","year":"2020","journal-title":"Front. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2529","article-title":"The genetic landscape of high-risk neuroblastoma.","volume":"45","author":"Pugh","year":"2013","journal-title":"Nat. Genet."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for rna-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2234","article-title":"T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and Her2-positive breast cancers.","volume":"11","author":"Rody","year":"2009","journal-title":"Breast Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"E1084","DOI":"10.1152\/ajpendo.00448.2020","article-title":"Loss of Ctrp4 alters adiposity and food intake behaviors in obese mice.","volume":"319","author":"Sarver","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850745","article-title":"Identification and validation of a novel signature based on Nk cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma by integrated analysis of single-cell and bulk Rna-sequencing.","volume":"13","author":"Song","year":"2022","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1593\/neo.121114","article-title":"High genomic instability predicts survival in metastatic high-risk neuroblastoma.","volume":"14","author":"Stigliani","year":"2012","journal-title":"Neoplasia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"Mrna-seq whole-transcriptome analysis of a single cell.","volume":"6","author":"Tang","year":"2009","journal-title":"Nat. Methods"},{"key":"B50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(sici)1097-0258(19970228)16:4<385:aid-sim380<3.0.co;2-3","article-title":"The lasso method for variable selection in the cox model.","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/epi.12.21","article-title":"Complete pipeline for infinium((R)) human methylation 450k beadchip data processing using subset quantile normalization for accurate DNA methylation estimation.","volume":"4","author":"Touleimat","year":"2012","journal-title":"Epigenomics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"19190","DOI":"10.1073\/pnas.1208215109","article-title":"Functional mycn signature predicts outcome of neuroblastoma irrespective of mycn amplification.","volume":"109","author":"Valentijn","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(09)70154-8","article-title":"Predicting outcomes for children with neuroblastoma using a multigene-expression signature: A retrospective Siopen\/Cog\/Gpoh study.","volume":"10","author":"Vermeulen","year":"2009","journal-title":"Lancet Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/CBM-191196","article-title":"Five-gene signature derived from M6a regulators to improve prognosis prediction of neuroblastoma.","volume":"28","author":"Wang","year":"2020","journal-title":"Cancer Biomark."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1158\/1078-0432.CCR-18-0599","article-title":"Clinically relevant cytotoxic immune cell signatures and clonal expansion of T-Cell receptors in high-risk mycn-not-amplified human neuroblastoma.","volume":"24","author":"Wei","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50796","article-title":"Cdc7 activates replication checkpoint by phosphorylating the Chk1-binding domain of claspin in human cells.","volume":"8","author":"Yang","year":"2019","journal-title":"Elife"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.7150\/ijbs.48126","article-title":"Downregulation of Meg3 promotes neuroblastoma development through Foxo1-mediated autophagy and mtor-mediated epithelial-mesenchymal transition.","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: An R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1080\/15384101.2018.1542898","article-title":"Mapt (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.","volume":"17","author":"Zaman","year":"2018","journal-title":"Cell Cycle"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0694-1","article-title":"Comparison of Rna-Seq and microarray-based models for clinical endpoint prediction.","volume":"16","author":"Zhang","year":"2015","journal-title":"Genome Biol."}],"container-title":["Frontiers in Neuroinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fninf.2022.1034793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T12:44:44Z","timestamp":1668084284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fninf.2022.1034793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":61,"alternative-id":["10.3389\/fninf.2022.1034793"],"URL":"https:\/\/doi.org\/10.3389\/fninf.2022.1034793","relation":{},"ISSN":["1662-5196"],"issn-type":[{"value":"1662-5196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"1034793"}}